Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Dec;40(12):2779-2789.
doi: 10.1007/s11095-023-03522-z. Epub 2023 May 1.

Computational and Experimental Screening Approaches to Aripiprazole Salt Crystallization

Harsh S Shah  1 , Caroline Michelle  2 , Tian Xie  2 , Kaushalendra Chaturvedi  2 , Shanming Kuang  2 , Yuriy A Abramov  3   4
Affiliations

Computational and Experimental Screening Approaches to Aripiprazole Salt Crystallization

Harsh S Shah et al. Pharm Res. 2023 Dec.

Abstract

Introduction: The screening of multicomponent crystal system (MCC) is a key method for improving physicochemical properties of active pharmaceutical ingredients (APIs). The challenges associated with experimental salt screening include a large number of potential counterions and solvent systems and tendency to undergo disproportionation to produce free form during crystallization. These challenges may be mitigated by a combination of experimental and computational approaches to salt screening. The goal of this study is to evaluate performance of the counterion screening methods and propose and validate novel approaches to virtual solvent screening for MCC crystallization.

Methods: The actual performance of the ΔpKa > 3 rule for counterion selection was validated using multiple screenings reports. Novel computational models for virtual solvent screening to avoid MCC incongruent crystallization were proposed. Using the ΔpKa rule, 10 acid counterions were selected for experimental aripiprazole (APZ) salt screening using 10 organic solvents. The experimental results were used to validate the proposed novel virtual solvent screen models.

Results: Experimental APZ salt screening resulted in a total of eight MCCs which included glucuronate, mesylate, oxalate, tartrate, salicylate and mandelate. The new model to virtually screen solvents provided a general agreement with APZ experimental findings in terms of selecting the optimal solvent for MCC crystallization.

Conclusion: The rational selection of counterions and organic solvents for MCC crystallization was presented using combined novel computational model as well as experimental studies. The current virtual solvent screen model was successfully implemented and validated which can be easily applied to newly discovered APIs.

Keywords: crystallization; modeling; multicomponent crystals; salt screening; virtual screening.

PubMed Disclaimer

References

    1. Newman A, Wenslow R. Solid form changes during drug development: good, bad, and ugly case studies. AAPS Open. 2016;2(1):2. - DOI
    1. Aitipamula S, Banerjee R, Bansal AK, Biradha K, Cheney ML, Choudhury AR, Desiraju GR, Dikundwar AG, Dubey R, Duggirala N. Polymorphs, salts, and cocrystals: what’s in a name? Cryst Growth Des. 2012;12(5):2147–52. - DOI
    1. Paulekuhn GS, Dressman JB, Saal C. Trends in active pharmaceutical ingredient salt selection based on analysis of the orange book database. J Med Chem. 2007;50(26):6665–72. - DOI - PubMed
    1. Morris KR, Fakes MG, Thakur AB, Newman AW, Singh AK, Venit JJ, Spagnuolo CJ, Serajuddin AT. An integrated approach to the selection of optimal salt form for a new drug candidate. Int J Pharm. 1994;105(3):209–17. - DOI
    1. Casares AF, Nap WM, Ten Figás G, Huizenga P, Groot R, Hoffmann M. An evaluation of salt screening methodologies. J Pharm Pharmacol. 2015;67(6):812–22. - DOI

LinkOut - more resources